| Literature DB >> 31485230 |
Zehra Betul Ahi1, Nergis Zeynep Renkler1, Mine Gul Seker2, Kadriye Tuzlakoglu1.
Abstract
Biodegradable composite membranes containing propolis were produced from PCL/PLLA blends using a simple and low-cost solvent casting method, and subsequently their physicochemical, mechanical, and antibacterial properties were characterized. SEM analysis revealed that the addition of propolis has created honeycomb-like structures on the film surfaces. The flexibility of the films increased in the presence of propolis, which may provide ease of use during application. Propolis disrupted the organized structure of both polymers at the molecular level and caused decreases in the melting points. The films with propolis showed faster degradation in physiological conditions due to this molecular disruption. Moreover, the PLLA/PCL/propolis composite films exhibited remarkable antibacterial activities against S. aureus. Collectively, the data suggest that the produced films might be used as an alternative to exiting barrier membranes in guided tissue regeneration.Entities:
Year: 2019 PMID: 31485230 PMCID: PMC6710769 DOI: 10.1155/2019/7932470
Source DB: PubMed Journal: Int J Biomater ISSN: 1687-8787
Figure 1SEM micrographs of the surface of the produced film: (a) neat PCL; (b) neat PLLA; (c) PLLA9-PCL1; (d) PCL/P; (e) PLLA/P; (f) PLLA9-PCL1/P.
Figure 2FTIR spectra for the films without/with propolis.
DSC results of films without/with propolis.
|
|
|
| |
|---|---|---|---|
| PCL | −60 | — | 62.52 |
| PCL/P | −23.10 | — | 47.08 |
| PLLA7-PCL3 | 46.57 | 178.86 | 52.15 |
| PLLA7-PCL3/P | 43.87 | 161.85 | 68.07 |
| PLLA8-PCL2 | 42.85 | 178.79 | 54.24 |
| PLLA9-PCL1 | 44.64 | 178.99 | 57.32 |
| PLLA9-PCL1/P | 34.61 | 165.02 | 39.44 |
| PLLA | 52.32 | 180.03 | — |
| PLLA/P | 37.94 | 164.08 | — |
Mechanical properties of films without/with propolis.
|
|
| |
|---|---|---|
| PCL | 247 ± 8 | 980 ± 94 |
| PCL/P | 20.5 ± 7 | 320 ± 9 |
| PLLA7-PCL3 | 339 ± 63 | 160 ± 14 |
| PLLA7-PCL3/P | 122 ± 6 | 130 ± 21 |
| PLLA8-PCL2 | 684 ± 27 | 220 ± 25 |
| PLLA8-PCL2/P | 319 ± 13 | 133 ± 16 |
| PLLA9-PCL1 | 818 ± 9 | 240 ± 19 |
| PLLA9-PCL1/P | 336 ± 11 | 200 ± 15 |
| PLLA | 829 ± 17 | 170 ± 2 |
| PLLA/P | 226 ± 10 | 210 ± 4 |
Figure 3Weight loss of the produced film after incubation in degradation solutions containing α-amylase at 37°C (n=3).
Figure 4Zone of inhibition formed by films against Staphylococcus aureus.
Antibacterial activity of the prepared films.
| (+) control | (−) control | PLLA/P | PCL/P | PLLA7-PCL3/P | PLLA8-PCL2/P | PLLA9-PCL1/P | |
|---|---|---|---|---|---|---|---|
| Antibacterial activity | + | − | + | + | + | + | + |
| Inhibition zone diameter (mm) | 27 | − | 17 | 15 | 17 | 13 | 13 |